| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |